Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2012 Jun 12;36(6):890. doi: 10.1038/ijo.2011.203

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide

A Astrup, R Carraro, N Finer, A Harper, M Kunesova, M E J Lean, L Niskanen, M F Rasmussen, A Rissanen, S Rössner, M J Savolainen, L Van Gaal, on behalf of the NN8022-1807 Investigators
PMCID: PMC3461573

Correction to: International Journal of Obesity advance online publication 16 August 2011; doi: 10.1038/ijo.2011.158

Since the publication of this article the authors have noticed an error in one of the figures (Figure 4A). This error has now been rectified and the corrected article appears in this issue. The html and online pdf versions have also been rectified and now carry the correct figure.

The authors would like to apologize for this error.


Articles from International Journal of Obesity (2005) are provided here courtesy of Nature Publishing Group

RESOURCES